Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × ALT-803 × 30 days × Clear all

Sponsor

Conditions

Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasm, Residual 1 Lymphoma, B-Cell 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma 1

Interventions

pembrolizumab 9 Cisplatin 6 Carboplatin 4 Radiotherapy, Intensity-Modulated 3 Docetaxel 3 Cyclophosphamide 3 Cetuximab 3 fludarabine 2 aldesleukin 2 Radiotherapy 2 Paclitaxel 2 Nivolumab 2 lenvatinib 1 fludarabine phosphate 1 ficlatuzumab 1 cemiplimab 1 atezolizumab 1 alpha-2'-deoxythioguanosine 1 Watchful Waiting 1 Taxes 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy, Image-Guided 1 Radiation 1 Proton Therapy 1 Platinum Compounds 1 Platinum 1 Pemetrexed 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡